Chemoinformaics analysis of 15-HYDROXY-ABIETIC-ACID
| Molecular Weight | 318.457 | nRot | 2 |
| Heavy Atom Molecular Weight | 288.217 | nRig | 17 |
| Exact Molecular Weight | 318.219 | nRing | 3 |
| Solubility: LogS | -3.778 | nHRing | 0 |
| Solubility: LogP | 3.2 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.8098 |
| nHD | 2 | BPOL | 30.9642 |
| QED | 0.797 |
| Synth | 4.376 |
| Natural Product Likeliness | 2.86 |
| NR-PPAR-gamma | 0.212 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.023 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -5.031 |
| MDCK | 0.0000182 |
| BBB | 0.206 |
| PPB | 0.93879 |
| VDSS | 0.622 |
| FU | 0.051297 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.46 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.874 |
| CYP2c9-inh | 0.092 |
| CYP2c9-sub | 0.575 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.24 |
| CYP3a4-inh | 0.053 |
| CYP3a4-sub | 0.255 |
| CL | 0.889 |
| T12 | 0.562 |
| hERG | 0.012 |
| Ames | 0.006 |
| ROA | 0.024 |
| SkinSen | 0.658 |
| Carcinogencity | 0.516 |
| EI | 0.057 |
| Respiratory | 0.888 |
| NR-Aromatase | 0.073 |
| Antiviral | No |
| Prediction | 0.6599 |